Interferon-β
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study
9
Erratum to: Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB
5
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
7
Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies
8
Long-term Outcome of Schilder Disease Treated With Interferon-β
7
In vitro inhibition of monkeypox virus production and spread by Interferon β
15
Interferon β attenuates lung inflammation following experimental subarachnoid hemorrhage
6
Arthritis suppression by NADPH activation operates through an interferon-β pathway
19
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS
10
An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production In KERTr Cells
10
Interferon β for treatment of rheumatoid arthritis?
7
Promyelocytic leukemia protein isoform II promotes transcription factor recruitment to activate interferon β and interferon responsive gene expression
14
Pathogenic Effects of IFIT2 and Interferon β during Fatal Systemic Candida albicans Infection
17
Schweninger, Christian (2012): Die Rolle von zytosolischer DNA in der Pathogenese des Diabetes mellitus Typ 1. Dissertation, LMU München: Medizinische Fakultät
113
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
11
Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis
8
Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer
10
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
9
The clinical potential of blood-proteomics in multiple sclerosis
8
The immunology of traumatic brain injury: a prime target for Alzheimer’s disease prevention
8